Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial.
Birnbaum W, Marshall L, Werner R, Kulle A, Holterhus PM, Rall K, Köhler B, Richter-Unruh A, Hartmann MF, Wudy SA, Auer MK, Lux A, Kropf S, Hiort O. Birnbaum W, et al. Among authors: kropf s. Lancet Diabetes Endocrinol. 2018 Oct;6(10):771-780. doi: 10.1016/S2213-8587(18)30197-9. Epub 2018 Jul 31. Lancet Diabetes Endocrinol. 2018. PMID: 30075954 Clinical Trial.
A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne.
Thielitz A, Lux A, Wiede A, Kropf S, Papakonstantinou E, Gollnick H. Thielitz A, et al. Among authors: kropf s. J Eur Acad Dermatol Venereol. 2015 Apr;29(4):789-96. doi: 10.1111/jdv.12823. Epub 2014 Nov 14. J Eur Acad Dermatol Venereol. 2015. PMID: 25399481 Clinical Trial.
Rationale for and design of the CREATIVE-AF trial: randomized, double-blind, placebo-controlled, crossover study of the effect of irbesartan on oxidative stress and adhesion molecules in patients with persistent atrial fibrillation.
Goette A, D'Alessandro A, Bukowska A, Kropf S, Mewis C, Stellbrink C, Tebbenjohanns J, Weiss C, Lendeckel U. Goette A, et al. Among authors: kropf s. Clin Drug Investig. 2008;28(9):565-72. doi: 10.2165/00044011-200828090-00003. Clin Drug Investig. 2008. PMID: 18666803 Clinical Trial.
228 results